S&P/ASX 200 Index (ASX: XJO) shares rose by 2.77% and delivered total returns, including dividends, of 7% in FY26.

As a new financial year begins, brokers have indicated continuing confidence in several ASX 200 shares.

This week, they renewed their buy calls on the following stocks, with updated 12-month price targets for FY27. 

A group of hands up in the air as if signifying a hearty vote in favour of a motion.

Image source: Getty Images

Over FY26, the market’s largest ASX 200 mining share skyrocketed 62% to close out the year at $59.40. 

Morgan Stanley renewed its buy rating on BHP shares this week.

The broker has a 12-month price target of $67.50. 

This suggests more than 10% upside over FY27. 

Northern Star Resources Ltd (ASX: NST)

The market’s largest ASX 200 gold mining share rose just 2% to $18.95 over FY26.

UBS reiterated its buy rating on Northern Resources shares this week.

The broker reduced its price target from $24.35 to $23.75. 

This implies potential capital gains of 25% ahead.

ANZ Group Holdings Ltd (ASX: ANZ)

This ASX 200 bank share rose 21% to close out the financial year at $35.35. 

Citi reaffirmed its buy rating on ANZ shares with a price target of $39.25.

This implies potential capital gains of 11% in the new financial year. 

Mineral Resources Ltd (ASX: MIN)

The stock price of this diversified ASX 200 miner rebounded 188% to $62.07 in FY26. 

UBS reaffirmed its buy rating on Mineral Resources shares this week.

The broker lowered its price target from $83 to $79.

This implies potential capital gains of 27% ahead in FY27. 

JB Hi Fi Ltd (ASX: JBH) 

Over FY26, this ASX 200 retail share tumbled 27% to $80.48.

Bell Potter reiterated its buy rating on JB Hi-Fi shares with a price target of $87.

This implies potential capital gains of 8% over FY27.

Neuren Pharmaceuticals Ltd (ASX: NEU)

This ASX 200 healthcare share rose 26% to $17.75 in FY26. 

Bell Potter reiterated its buy rating on Neuren Pharmaceuticals shares this week.

The broker boosted its 12-month share price target from $22 to $23.50. 

This implies potential capital gains of 32% ahead.

Resolute Mining Ltd (ASX: RSG)

Over FY26, this ASX 200 gold stock ripped 56% to 95 cents per share. 

Macquarie renewed its buy rating on Resolute Mining shares with a price target of $1.55.

This implies potential capital gains of 64% for FY27. 

BlueScope Steel Ltd (ASX: BSL)

The BlueScope Steel share price rose 38% over FY26 to close at $31.87. 

RBC Capital renewed its buy rating on the ASX 200 materials share this week. 

The broker raised its 12-month price target from $35.25 to $38.25.

This suggests a potential 20% upside ahead.

Over FY26, this ASX 200 mining share rose 34% to finish the year at $3.90. 

UBS reaffirmed its buy rating on South32 shares with a reduced price target of $5.

This implies potential capital gains of 28% ahead.